1. Home
  2. TRVI vs NWN Comparison

TRVI vs NWN Comparison

Compare TRVI & NWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

HOLD

Current Price

$18.46

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Northwest Natural Holding Company

NWN

Northwest Natural Holding Company

HOLD

Current Price

$50.86

Market Cap

2.2B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRVI
NWN
Founded
2011
1859
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil/Gas Transmission
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.2B
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
TRVI
NWN
Price
$18.46
$50.86
Analyst Decision
Strong Buy
Buy
Analyst Count
11
3
Target Price
$21.55
$54.33
AVG Volume (30 Days)
2.1M
187.9K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
3.71%
EPS Growth
31.91
36.45
EPS
N/A
2.33
Revenue
N/A
$1,289,363,000.00
Revenue This Year
N/A
$11.37
Revenue Next Year
N/A
$4.46
P/E Ratio
N/A
$21.81
Revenue Growth
N/A
11.83
52 Week Low
$6.93
$39.98
52 Week High
$20.22
$55.99

Technical Indicators

Market Signals
Indicator
TRVI
NWN
Relative Strength Index (RSI) 55.11 53.97
Support Level $17.46 $48.33
Resistance Level $19.89 $52.19
Average True Range (ATR) 0.87 0.96
MACD -0.07 0.05
Stochastic Oscillator 56.37 58.80

Price Performance

Historical Comparison
TRVI
NWN

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

About NWN Northwest Natural Holding Company

Northwest Natural Holding Co is a public natural gas service supplier operating in the U.S. Pacific Northwest. Its subsidiary, NW Natural, operates through the natural gas distribution segment, which purchases and distributes natural gas through which operates in Oregon and southwest Washington. The company operates in three reportable business segments, which are NWN Gas Utility, SiEnergy, and NWN Water. The company generates maximum revenue from NWN Gas Utility segment. It also generates revenue from residential, commercial, and industrial customers, the majority of which are in Oregon. Residential and commercial customers account for the vast majority of profitability.

Share on Social Networks: